Drivers and Regulators of Humoral Innate Immune Responses to Infection and Cancer

Overview

Journal Mol Immunol

Specialties Allergy & Immunology
Molecular Biology

Date 2020 Mar 22

PMID 32199212

Citations 9

Authors

Deepak Kumar

Yeni Romero

Kaitlynn N Schuck

Haley Smalley

Bibek Subedi

Sherry D Fleming

Affiliations

Soon will be listed here.

Abstract

The complement cascade consists of cell bound and serum proteins acting together to protect the host from pathogens, remove cancerous cells and effectively links innate and adaptive immune responses. Despite its usefulness in microbial neutralization and clearance of cancerous cells, excessive complement activation causes an immune imbalance and tissue damage in the host. Hence, a series of complement regulatory proteins present at a higher concentration in blood plasma and on cell surfaces tightly regulate the cascade. The complement cascade can be initiated by B-1 B cell production of natural antibodies. Natural antibodies arise spontaneously without any known exogenous antigenic or microbial stimulus and protect against invading pathogens, clear apoptotic cells, provide tissue homeostasis, and modulate adaptive immune functions. Natural IgM antibodies recognize microbial and cancer antigens and serve as an activator of complement mediated lysis. This review will discuss advances in complement activation and regulation in bacterial and viral infections, and cancer. We will also explore the crosstalk of natural antibodies with bacterial populations and cancer.

Citing Articles

Based on the prognosis model of immunogenes, the prognosis model was constructed to predict the invasion of immune genes and immune cells related to primary liver cancer and its experimental validation.

Yang Y, Bai M, Cheng Y, Feng X, Zhang Y, Zhang Y Heliyon. 2024; 10(7):e27362.

PMID: 38560168 PMC: 10980948. DOI: 10.1016/j.heliyon.2024.e27362.

Delivery of a novel membrane-anchored Fc chimera enhances NK cell-mediated killing of tumor cells and persistently virus-infected cells.

Varudkar N, Shiffer E, Oyer J, Copik A, Parks G PLoS One. 2023; 18(5):e0285532.

PMID: 37146009 PMC: 10162523. DOI: 10.1371/journal.pone.0285532.

Diversity of immune responses in children highly exposed to SARS-CoV-2.

Ubeda M, Maza M, Delgado P, Horndler L, Abia D, Garcia-Bermejo L Front Immunol. 2023; 14:1105237.

PMID: 36936972 PMC: 10020361. DOI: 10.3389/fimmu.2023.1105237.

The Forgotten Brother: The Innate-like B1 Cell in Multiple Sclerosis.

Halperin S, t Hart B, Luchicchi A, Schenk G Biomedicines. 2022; 10(3).

PMID: 35327408 PMC: 8945227. DOI: 10.3390/biomedicines10030606.

Increased Serum Pentraxin 3 Levels are Associated with Poor Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma.

Han Q, Deng H, Fan X, Wang X, Zhang X, Zhang K J Hepatocell Carcinoma. 2021; 8:1367-1373.

PMID: 34805015 PMC: 8598127. DOI: 10.2147/JHC.S337936.

References

Loomes L, Uemura K, Feizi T . Interaction of Mycoplasma pneumoniae with erythrocyte glycolipids of I and i antigen types. Infect Immun. 1985; 47(1):15-20. PMC: 261450. DOI: 10.1128/iai.47.1.15-20.1985. View

Martin F, Oliver A, Kearney J . Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity. 2001; 14(5):617-29. DOI: 10.1016/s1074-7613(01)00129-7. View

Martin F, Kearney J . B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a "natural immune memory". Immunol Rev. 2000; 175:70-9. View

Su Y, Liu Y, Behrens C, Bidlingmaier S, Lee N, Aggarwal R . Targeting CD46 for both adenocarcinoma and neuroendocrine prostate cancer. JCI Insight. 2018; 3(17). PMC: 6171802. DOI: 10.1172/jci.insight.121497. View

Douradinha B, McBurney S, Soares de Melo K, Smith A, Krishna N, Barratt-Boyes S . C1q binding to dengue virus decreases levels of infection and inflammatory molecules transcription in THP-1 cells. Virus Res. 2013; 179:231-4. PMC: 3946857. DOI: 10.1016/j.virusres.2013.11.007. View

Xu C, Jung M, Burkhardt M, Stephan C, Schnorr D, Loening S . Increased CD59 protein expression predicts a PSA relapse in patients after radical prostatectomy. Prostate. 2004; 62(3):224-32. DOI: 10.1002/pros.20134. View

Okroj M, Hsu Y, Ajona D, Pio R, Blom A . Non-small cell lung cancer cells produce a functional set of complement factor I and its soluble cofactors. Mol Immunol. 2007; 45(1):169-79. DOI: 10.1016/j.molimm.2007.04.025. View

Trouw L, Nilsson S, Goncalves I, Landberg G, Blom A . C4b-binding protein binds to necrotic cells and DNA, limiting DNA release and inhibiting complement activation. J Exp Med. 2005; 201(12):1937-48. PMC: 2212022. DOI: 10.1084/jem.20050189. View

Kolev M, Markiewski M . Targeting complement-mediated immunoregulation for cancer immunotherapy. Semin Immunol. 2018; 37:85-97. PMC: 5984681. DOI: 10.1016/j.smim.2018.02.003. View

10.

Hayakawa K, Formica A, Brill-Dashoff J, Shinton S, Ichikawa D, Zhou Y . Early generated B1 B cells with restricted BCRs become chronic lymphocytic leukemia with continued c-Myc and low Bmf expression. J Exp Med. 2016; 213(13):3007-3024. PMC: 5154941. DOI: 10.1084/jem.20160712. View

11.

Meri T, Amdahl H, Lehtinen M, Hyvarinen S, McDowell J, Bhattacharjee A . Microbes bind complement inhibitor factor H via a common site. PLoS Pathog. 2013; 9(4):e1003308. PMC: 3630169. DOI: 10.1371/journal.ppat.1003308. View

12.

Verschoor A, Brockman M, Gadjeva M, Knipe D, Carroll M . Myeloid C3 determines induction of humoral responses to peripheral herpes simplex virus infection. J Immunol. 2003; 171(10):5363-71. DOI: 10.4049/jimmunol.171.10.5363. View

13.

Diaz-Zaragoza M, Hernandez-Avila R, Ostoa-Saloma P . Recognition of tumor antigens in 4T1 cells by natural IgM from three strains of mice with different susceptibilities to spontaneous breast cancer. Oncol Lett. 2017; 13(1):271-274. PMC: 5244975. DOI: 10.3892/ol.2016.5427. View

14.

Golay J, Zaffaroni L, Vaccari T, Lazzari M, Borleri G, Bernasconi S . Biologic response of B lymphoma cells to anti-CD20 monoclonal antibody rituximab in vitro: CD55 and CD59 regulate complement-mediated cell lysis. Blood. 2000; 95(12):3900-8. View

15.

Pausa M, Pellis V, Cinco M, Giulianini P, Presani G, Perticarari S . Serum-resistant strains of Borrelia burgdorferi evade complement-mediated killing by expressing a CD59-like complement inhibitory molecule. J Immunol. 2003; 170(6):3214-22. DOI: 10.4049/jimmunol.170.6.3214. View

16.

Kononchik Jr J, Hernandez R, Brown D . An alternative pathway for alphavirus entry. Virol J. 2011; 8:304. PMC: 3315796. DOI: 10.1186/1743-422X-8-304. View

17.

Shulzhenko N, Morgun A, Hsiao W, Battle M, Yao M, Gavrilova O . Crosstalk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut. Nat Med. 2011; 17(12):1585-93. PMC: 3902046. DOI: 10.1038/nm.2505. View

18.

Holodick N, Rodriguez-Zhurbenko N, Hernandez A . Defining Natural Antibodies. Front Immunol. 2017; 8:872. PMC: 5526850. DOI: 10.3389/fimmu.2017.00872. View

19.

Thurlow L, Thomas V, Fleming S, Hancock L . Enterococcus faecalis capsular polysaccharide serotypes C and D and their contributions to host innate immune evasion. Infect Immun. 2009; 77(12):5551-7. PMC: 2786471. DOI: 10.1128/IAI.00576-09. View

20.

Thurlow L, Thomas V, Narayanan S, Olson S, Fleming S, Hancock L . Gelatinase contributes to the pathogenesis of endocarditis caused by Enterococcus faecalis. Infect Immun. 2010; 78(11):4936-43. PMC: 2976315. DOI: 10.1128/IAI.01118-09. View